Ewa Wunsch

14PUBLICATIONS
31CO-AUTHORS
Medical biochemistry - lipidsLiquid biopsiesCardiology (incl. cardiovascular diseases)Epidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 06, 2026
Do Current Data Support the Use of Essential Phospholipids in MASLD? A Comment on Stefan et al.

|Mar 29, 2023
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?

Anna Gudan, Katarzyna Kozłowska-Petriczko, Ewa Wunsch

|Nov 11, 2022
PR3-ANCAs Detected by Third-Generation ELISA Predicts Severe Disease and Poor Survival in Primary Sclerosing Cholangitis.

Steffi Lopens, Ewa Wunsch, Malgorzata Milkiewicz

|Sep 30, 2022
Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE-LIVER online survey.

Ewa Wunsch, Linda Krause, Tom Jg Gevers

|May 10, 2022
Impact on follow-up strategies in patients with primary sclerosing cholangitis.

Annika Bergquist, Tobias J Weismüller, Cynthia Levy

|Apr 30, 2021
Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference.

Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko

Pageof 3